Skip to content

LivaNova LIVN Other Noncash Income (Expense)

Other Noncash Income (Expense) at other companies

Medtronic logo
MedtronicMDT
Baxter International logo
Baxter InternationalBAX
Nordson logo
NordsonNDSN

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's other noncash income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's other noncash income (expense)?
LivaNova (LIVN) reported other noncash income (expense) of -$1.17M in Q1 2026.
How has LivaNova's other noncash income (expense) changed year-over-year?
LivaNova's other noncash income (expense) decreased by 10572.7% year-over-year, from -$11K to -$1.17M.
What is the long-term trend for LivaNova's other noncash income (expense)?
Over 3 years (2022 to 2025), LivaNova's other noncash income (expense) has grown at a 24.5% compound annual growth rate (CAGR), from -$1.65M to -$3.19M.